What is Mechanical Thrombectomy Devices Market?
Mechanical thrombectomy devices comprise a wide array of endovascular tools cleared for removing thrombi from the neurovasculature in acute ischemic stroke patients. Mechanical thrombectomy devices seek to salvage ischemic, but not yet fully infarcted, brain by restoring perfusion through the initially occluded artery. The rising number of minimally invasive procedures, the growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of the global mechanical thrombectomy devices market.
The market study is being classified by Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Others), by Application (Cardiovascular, Peripheral Vascular and Neurovascular) and major geographies with country level break-up.
Medtronic plc (Ireland), Boston Scientific Corporation (United States), Johnson & Johnson (United States), Terumo Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Penumbra, Inc. (United States), Abbott Laboratories (United States), Acandis GmbH (Germany), AngioDynamics, Inc. (United States), Minnetronix Medical Inc. (United States), Penumbra (United States) and Stryker (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Spectranetics Corporation (United States), Edwards Lifesciences Corporation (United States), Argon Medical Devices, Inc. (United States) and Teleflex Incorporated (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Mechanical Thrombectomy Devices market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Mechanical Thrombectomy Devices market by Type, Application and Region.
On the basis of geography, the market of Mechanical Thrombectomy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Target Patient Population
- Increasing Healthcare Expenditure Across Emerging Markets
- Rising Demand for Minimally Invasive Thrombectomy Procedures
Market Trend
- Favorable Medical Reimbursement Scenario
Restraints
- Stringent Regulatory Scenario
Opportunities
- Increasing Number of Research Activities in the Field of Thrombectomy
- Expanding Application of Ultrasound in Vascular Treatment
Challenges
- Limited Availability of Clinical Data to Validate the Therapeutic Efficacy of Clot Retrieval Devices
Market Leaders and some development strategies
On 24th September 2020, Royal Philips, a global leader in health technology, has announced the launch of the innovative QuickClear mechanical thrombectomy system. The compact, single-use system provides an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems.
On 6th May 2020, Control Medical Technology announced the FDA cleared the Aspire MAX 7 – 11F Mechanical Thrombectomy platform to remove blood clots from peripheral vessels.
Key Target Audience
Mechanical Thrombectomy Devices Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others